Mutations and aneuploidy: Co-conspirators in cancer?

Cancer Cell

Volumn 4, Issue 2, 2003, Pages 89-94

  Pihan, German ^a   Doxsey, Stephen J ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BASE; DOUBLE STRANDED DNA; FLT3 LIGAND; STEM CELL FACTOR;

ATAXIA TELANGIECTASIA; CANCER INCIDENCE; CARCINOGENESIS; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CHROMOSOME BREAKAGE; CHROMOSOME LOSS; CHROMOSOME MUTATION; CHROMOSOME NOR; CHROMOSOME STRUCTURE; COLON CARCINOGENESIS; COLON CARCINOMA; DNA STRAND BREAKAGE; EXCISION REPAIR; GENE AMPLIFICATION; GENE CONTROL; GENE DOSAGE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE MUTATION; GENE STRUCTURE; GENE TRANSLOCATION; GENETIC EPISTASIS; HUMAN; KARYOTYPE 47,XYY; MITOSIS RATE; MUTATION RATE; ONCOGENE RAS; PHENOTYPIC PLASTICITY; POINT MUTATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TELOMERE;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 0041883657     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(03)00195-8     Document Type: Review

References (50)

1. Andreassen P.R., Lohez O.D., Lacroix F.B., Margolis R.L. Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1. Mol. Biol. Cell. 12:2001;1315-1328.
2. Artandi S.E., Chang S., Lee S.L., Alson S., Gottlieb G.J., Chin L., DePinho R.A. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature. 406:2000;641-645.
3. Balmain A. Cancer genetics. from Boveri and Mendel to microarrays Nat. Rev. Cancer. 1:2001;77-82.
4. Balzer F. Theodore Boveri. Life and Work of Great Biologist:1967;University of California Press, Berkeley.
5. Boveri T. Zur Frage der Entstehung Maligner Tumoren. 1914;Gustav Fisher, Jena, Germany.
6. Chang S., Khoo C., DePinho R.A. Modeling chromosomal instability and epithelial carcinogenesis in the telomerase-deficient mouse. Semin. Cancer Biol. 11:2001;227-239.
7. Chin L., Artandi S.E., Shen Q., Tam A., Lee S.L., Gottlieb G.J., Greider C.W., DePinho R.A. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell. 97:1999;527-538.
8. Difilippantonio M.J., Petersen S., Chen H.T., Johnson R., Jasin M., Kanaar R., Ried T., Nussenzweig A. Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification. J. Exp. Med. 196:2002;469-480.
9. Fodde R., Smits R. Cancer biology. A matter of dosage. Science. 298:2002;761-763.
10. Frei E. 3rd. Gene deletion. a new target for cancer chemotherapy Lancet. 342:1993;662-664.
11. Friedberg E.C. How nucleotide excision repair protects against cancer. Nat. Rev. Cancer. 1:2001;22-33.
12. Gisselsson D. Chromosome instability in cancer. how, when, and why? Adv. Cancer Res. 87:2003;1-29.
13. Hahn W.C., Weinberg R.A. Rules for making human tumor cells. N. Engl. J. Med. 347:2002;1593-1603.
14. Heim S., Mitelman F. Cancer Cytogenetics. Second Edition:1995;John Wiley & Sons, New York.
15. Hoeijmakers J.H. Genome maintenance mechanisms for preventing cancer. Nature. 411:2001;366-374.
16. Hunter T. Oncoprotein networks. Cell. 88:1997;333-346.
17. Imreh S., Kost-Alimova M., Kholodnyuk I., Yang Y., Szeles A., Kiss H., Liu Y., Foster K., Zabarovsky E., Stanbridge E., Klein G. Differential elimination of 3p and retention of 3q segments in human/mouse microcell hybrids during tumor growth. Genes Chromosomes Cancer. 20:1997;224-233.
18. Jallepalli P.V., Lengauer C. Chromosome segregation and cancer. cutting through the mystery Nat. Rev. Cancer. 1:2001;109-117.
19. Kinzler K.W., Vogelstein B. Cancer-susceptibility genes. Gatekeepers and caretakers Nature. 386:1997;761-763.
20. Knudson A.G. Two genetic hits (more or less) to cancer. Nat. Rev. Cancer. 1:2001;157-162.
21. Knuutila S., Bjorkqvist A.M., Autio K., Tarkkanen M., Wolf M., Monni O., Szymanska J., Larramendy M.L., Tapper J., Pere H.et al. DNA copy number amplifications in human neoplasms. review of comparative genomic hybridization studies Am. J. Pathol. 152:1998;1107-1123.
22. Knuutila S., Aalto Y., Autio K., Bjorkqvist A.M., El-Rifai W., Hemmer S., Huhta T., Kettunen E., Kiuru-Kuhlefelt S., Larramendy M.L.et al. DNA copy number losses in human neoplasms. Am. J. Pathol. 155:1999;683-694.
23. Lengauer C. How do tumors make ends meet? Proc. Natl. Acad. Sci. USA. 98:2001;12331-12333.
24. Levine A.J., Momand J., Finlay C.A. The p53 tumour suppressor gene. Nature. 351:1991;453-456.
25. Li R., Sonik A., Stindl R., Rasnick D., Duesberg P. Aneuploidy vs. gene mutation hypothesis of cancer. recent study claims mutation but is found to support aneuploidy Proc. Natl. Acad. Sci. USA. 97:2000;3236-3241.
26. Loeb L.A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51:1991;3075-3079.
27. Marx J. Debate surges over the origins of genomic defects in cancer. Science. 297:2002;544-546.
28. Maser R.S., DePinho R.A. Take care of your chromosomes lest cancer take care of you. Cancer Cell. 3:2003;4-6.
29. Meyn M.S. Chromosome instability syndromes. Lessons for carcinogenesis Curr. Top. Microbiol. Immunol. 221:1997;71-148.
30. Mills K.D., Ferguson D.O., Alt F.W. The role of DNA breaks in genomic instability and tumorigenesis. Immunol. Rev. 194:2003;77-95.
31. Modrich P., Lahue R. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu. Rev. Biochem. 65:1996;101-133.
32. Muller H. Artificial transmutation of the gene. Science. 46:1927;84-87.
33. O'Hagan R.C., Chang S., Maser R.S., Mohan R., Artandi S.E., Chin L., DePinho R.A. Telomere dysfunction provokes regional amplification and deletion in cancer genomes. Cancer Cell. 2:2002;149-155.
34. Pihan G.A., Doxsey S.J. The mitotic machinery as a source of genetic instability in cancer. Semin. Cancer Biol. 9:1999;289-302.
35. Sahai E., Marshall C.J. RHO-GTPases and cancer. Nat. Rev. Cancer. 2:2002;133-142.
36. Saretzki G., Sitte N., Merkel U., Wurm R.E., von Zglinicki T. Telomere shortening triggers a p53-dependent cell cycle arrest via accumulation of G-rich single stranded DNA fragments. Oncogene. 18:1999;5148-5158.
37. Schrock E., du Manoir S., Veldman T., Schoell B., Wienberg J., Ferguson-Smith M.A., Ning Y., Ledbetter D.H., Bar-Am I., Soenksen D.et al. Multicolor spectral karyotyping of human chromosomes. Science. 273:1996;494-497.
38. Schwab M. Oncogene amplification in solid tumors. Semin. Cancer Biol. 9:1999;319-325.
39. Sharpless N.E., Ferguson D.O., O'Hagan R.C., Castrillon D.H., Lee C., Farazi P.A., Alson S., Fleming J., Morton C.C., Frank K.et al. Impaired nonhomologous end-joining provokes soft tissue sarcomas harboring chromosomal translocations, amplifications, and deletions. Mol. Cell. 8:2001;1187-1196.
40. Sherr C.J., McCormick F. The RB and p53 pathways in cancer. Cancer Cell. 2:2002;103-112.
41. Shiloh Y. ATM and related protein kinases. Safeguarding genome integrity Nat. Rev. Cancer. 3:2003;155-168.
42. Taipale J., Beachy P.A. The Hedgehog and Wnt signalling pathways in cancer. Nature. 411:2001;349-354.
43. Thiagalingam S., Laken S., Willson J.K., Markowitz S.D., Kinzler K.W., Vogelstein B., Lengauer C. Mechanisms underlying losses of heterozygosity in human colorectal cancers. Proc. Natl. Acad. Sci. USA. 98:2001;2698-2702.
44. Thompson L.H., Schild D. Recombinational DNA repair and human disease. Mutat. Res. 509:2002;49-78.
45. Tomlinson I.P., Novelli M.R., Bodmer W.F. The mutation rate and cancer. Proc. Natl. Acad. Sci. USA. 93:1996;14800-14803.
46. van Gent D.C., Hoeijmakers J.H., Kanaar R. Chromosomal stability and the DNA double-stranded break connection. Nat. Rev. Genet. 2:2001;196-206.
47. Vivanco I., Sawyers C.L. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer. 2:2002;489-501.
48. von Hansemann D. Uber asymmetrische zellteilung in epithelkrebsen und deren biologische bedeutung. Virchow's Arch Path Anat. 119:1890;299-326.
49. Wang T.L., Rago C., Silliman N., Ptak J., Markowitz S., Willson J.K., Parmigiani G., Kinzler K.W., Vogelstein B., Velculescu V.E. Prevalence of somatic alterations in the colorectal cancer cell genome. Proc. Natl. Acad. Sci. USA. 99:2002;3076-3080.
50. Weinberg R.A. Oncogenes and tumor suppressor genes. CA Cancer J. Clin. 44:1994;160-170.